AnalystBook Research · Company Intelligence

MUSTANG BIO, INC.

MBIONasdaq

Built from MUSTANG BIO, INC.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -69.95 distress zone — historically elevated failure riskWatch

Leadership changes

From MUSTANG BIO, INC.'s own filings, the day they're filed.

  • Manuel Litchman · Chief Financial Officer · appointmenteff. 2024-11-15
  • James Murphy · Chief Financial Officer · departureeff. 2024-11-12
  • James Murphy · Chief Financial Officer · appointmenteff. 2024-01-19

Latest filings

  • 10-Q · Quarterly report2026-08-05
  • 10-Q · Quarterly report2026-05-05
  • 8-K · Company announcement2026-04-17
  • 10-K · Annual report2026-03-19
  • 8-K · Company announcement2025-12-23
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about MUSTANG BIO, INC., every answer cited to the official filings🔒
  • The Intelligence Brief — added when MUSTANG BIO, INC.'s brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.